Peptide library
Teduglutide
Your guide to this compound.
Dose context
Product label context
Gattex labeling gives 0.05 mg/kg subcutaneously daily, reduced to 0.025 mg/kg for eGFR below 60 mL/min/1.73 m². This is label context, not individualized prescribing.
How to read this information
Catalog ranges can describe approved labeling, clinical research or unverified reports. They are not interchangeable and do not select a personal dose.
Half-life
GATTEX subcutaneous teduglutide: mean terminal half-life is approximately two hours in healthy subjects and 1.3 hours in adults with short bowel syndrome. Pediatric model estimates were about 0.7 hours at ages 1–11 and 1.0 hour at ages 12–17. Renal impairment increases exposure; these are population-specific estimates, not dose-selection rules.
Species, route and formulation matter. Half-life does not define a safe dosing interval.
Routes and frequency in the catalog
Storage
GATTEX 5 mg kits/vials: before dispensing, refrigerate at 2–8°C. After pharmacist dispensing, store up to 25°C with a 90-day use-by date; do not freeze or exceed expiry. Reconstituted solution must be used within three hours and unused solution discarded. These limits are presentation-specific.
Generic storage notes cannot establish a beyond-use date or sterility for a particular vial.
Preparation and reconstitution
Use the supplied GATTEX diluent and the exact kit instructions. After reconstitution, use within three hours, then discard any unused portion. This does not authorize a stored multidose research-vial preparation.